Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Invernizzi

Showing results (361-370 of 420) with videos related to

Pageof 42
Sort By:
Journal of Hepatology|March 15, 2023
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort<sup>☆</sup>" [J Hepatol (2020) 505-515]Quentin M Anstee, Rebecca Darlay, Simon Cockell, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2019
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment responseCarla F Murillo Perez, Gideon M Hirschfield, Christophe Corpechot, et al.
The Lancet. Gastroenterology & Hepatology|October 31, 2025
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trialMichael Trauner, Cynthia Levy, Atsushi Tanaka, et al.
Journal of Hepatology|April 17, 2020
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort<sup>☆</sup>Quentin M Anstee, Rebecca Darlay, Simon Cockell, et al.
European Journal of Gastroenterology & Hepatology|September 27, 2022
Continuous clinical remission with biologics in ulcerative colitis: the 'AURORA' comparison studyAndrea Cassinotti, Nicolò Mezzina, Annalisa De Silvestri, et al.
Hepatology (Baltimore, Md.)|March 16, 2021
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off ApproachLaura Cristoferi, Vincenza Calvaruso, Diletta Overi, et al.
JHEP Reports : Innovation in Hepatology|January 20, 2025
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitisAlessio Gerussi, Oliver Lester Saldanha, Giorgio Cazzaniga, et al.
European Journal of Gastroenterology & Hepatology|December 16, 2020
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment toolCarla F Murillo Perez, Aliya Gulamhusein, Marco Carbone, et al.
Alimentary Pharmacology & Therapeutics|September 23, 2022
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acidRozanne C de Veer, Maren H Harms, Christophe Corpechot, et al.
Autoimmunity Reviews|July 15, 2020
2020 international consensus on ANCA testing beyond systemic vasculitisSergey Moiseev, Jan Willem Cohen Tervaert, Yoshihiro Arimura, et al.
Pageof 42

Showing results (361-370 of 420) with videos related to

Sort By:
Pageof 42
Journal of Hepatology|March 15, 2023
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort<sup>☆</sup>" [J Hepatol (2020) 505-515]Quentin M Anstee, Rebecca Darlay, Simon Cockell, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2019
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment responseCarla F Murillo Perez, Gideon M Hirschfield, Christophe Corpechot, et al.
The Lancet. Gastroenterology & Hepatology|October 31, 2025
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trialMichael Trauner, Cynthia Levy, Atsushi Tanaka, et al.
Journal of Hepatology|April 17, 2020
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort<sup>☆</sup>Quentin M Anstee, Rebecca Darlay, Simon Cockell, et al.
European Journal of Gastroenterology & Hepatology|September 27, 2022
Continuous clinical remission with biologics in ulcerative colitis: the 'AURORA' comparison studyAndrea Cassinotti, Nicolò Mezzina, Annalisa De Silvestri, et al.
Hepatology (Baltimore, Md.)|March 16, 2021
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off ApproachLaura Cristoferi, Vincenza Calvaruso, Diletta Overi, et al.
JHEP Reports : Innovation in Hepatology|January 20, 2025
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitisAlessio Gerussi, Oliver Lester Saldanha, Giorgio Cazzaniga, et al.
European Journal of Gastroenterology & Hepatology|December 16, 2020
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment toolCarla F Murillo Perez, Aliya Gulamhusein, Marco Carbone, et al.
Alimentary Pharmacology & Therapeutics|September 23, 2022
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acidRozanne C de Veer, Maren H Harms, Christophe Corpechot, et al.
Autoimmunity Reviews|July 15, 2020
2020 international consensus on ANCA testing beyond systemic vasculitisSergey Moiseev, Jan Willem Cohen Tervaert, Yoshihiro Arimura, et al.
Pageof 42